Abstract

BackgroundTo determine a correlation between mRNA and lncRNA signatures, sonographic features, and risk of recurrence in triple-negative breast cancers (TNBC).MethodsWe retrospectively reviewed the data from 114 TNBC patients having undergone transcriptome analysis. The risk of tumor recurrence was determined based on the correlation between transcriptome profiles and recurrence-free survival. Ultrasound (US) features were described according to the Breast Imaging Reporting and Data System. Multivariate logistic regression analysis determined the correlation between US features and risk of recurrence. The predictive value of sonographic features in determining tumor recurrence was analyzed using receiver operating characteristic curves.ResultsThree mRNAs (CHRDL1, FCGR1A, and RSAD2) and two lncRNAs (HIF1A-AS2 and AK124454) were correlated with recurrence-free survival in patients with TNBC. Among the three mRNAs, two were upregulated (FCGR1A and RSAD2) and one was downregulated (CHRDL1) in TNBCs. LncRNAs HIF1A-AS2 and AK124454 were upregulated in TNBCs. Based on these signatures, an integrated mRNA–lncRNA model was established using Cox regression analysis to determine the risk of tumor recurrence. Benign-like sonographic features, such as regular shape, circumscribed margin, posterior acoustic enhancement, and no calcifications, were associated with HIF1A-AS2 expression and high risk of tumor recurrence (P<0.05). Malignant-like features, such as irregular shape, uncircumscribed margin, no posterior acoustic enhancement, and calcifications, were correlated with CHRDL1 expression and low risk of tumor recurrence (P<0.05).ConclusionsSonographic features and mRNA–lncRNA signatures in TNBCs represent the risk of tumor recurrence. Taken together, US may be a promising technique in determining the prognosis of patients with TNBC.

Highlights

  • To determine a correlation between messenger RNA (mRNA) and long non-coding RNA (lncRNA) signatures, sonographic features, and risk of recurrence in triple-negative breast cancers (TNBC)

  • Sonographic features and mRNA–lncRNA signatures in TNBCs represent the risk of tumor recurrence

  • Sonographic features of TNBCs correlated with the expression of mRNAs and lncRNAs

Read more

Summary

Introduction

To determine a correlation between mRNA and lncRNA signatures, sonographic features, and risk of recurrence in triple-negative breast cancers (TNBC). Numerous studies have analyzed the genome and transcriptome signatures to identify the therapeutic target for TNBCs [2,3,4,5,6]. Using the largest TNBC database at Fudan University Shanghai Cancer Center, a recent study confirmed the importance of personalized therapy based on the gene expression profile in patients with TNBC [3]. They found that PIK3CA mutations and LAR subtype are more common in Chinese TNBC patients. Substantial evidence was established for the biological heterogeneity of TNBCs based on the genomic and transcriptomic profiles [3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call